Nath Bio-Genes (Indi...
NSEI:NATHBIOGEN
Rp 147,96
+ Rp4,84 (3,38%)
147,96 Rp
+Rp4,84 (3,38%)
End-of-day quote: 04/08/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

Rp26,33
Earnings Per Share
Rp147,31
Revenue Per Share
75,28%
Gross Margin %
Rp2,81 B
Market Cap
Rp0,13 B
Long-Term Debt
Earnings Per Share
Rp26,33
Revenue Per Share
Rp147,31
Gross Margin %
75,28%
Market Cap
Rp2,81 B
Long-Term Debt
Rp0,13 B

Financials

Year Year 2025 2020
EPS Earnings Per Share Rp26,33 Rp26,33
Earnings Earnings Rp500,27M Rp500,27M
RPS Revenue Per Share Rp147,31 Rp147,31
Revenue Revenue Rp2,80B Rp2,80B
OCF Operating Cash Flow Rp0,00M Rp0,00M
FCF Free Cash Flow Rp0,00M Rp0,00M
OM Operating Margin 12,92% 19,07%
GM % Gross Margin % 75,28% 66,27%
FCFS Free Cash Flow Per Share Rp5,08 Rp-3,54
LT Debt Long-Term Debt Rp129,76M Rp3,00M
Sha. Stocks 19M 19M
×